Designated Country Infringing. Product Section 4.03 Disclosing Parties Section 2.04(b) Disclosing Party Section 2.04(b) DOJ Section 2.05(b) Effective Date Section 1.01 European Opposition Proceeding Section 1.01 Exclusive Designated Countries License Section 3.03 Exclusive U.S. License Section 3.02(a) Exclusive U.S. License Consideration Section 1.01 Exclusive U.S. License Effective Date Section 3.02(a) Exclusive U.S. License Notice Section 3.02(b) FDA Section 1.01 Filing Party Section 8.15(a) FTC Section 2.05(b) GAAP Section 1.01 German Proceedings Section 2.01(b)(ii) Governmental Entity Section 1.01 HSR Act Section 1.01 Infringed Claim Section 1.01 Infringing Products Section 1.01 Intellectual Property Section 1.01 Interference Proceeding Section 1.01 IP Advisory Committee Section 5.02 JAMS Section 8.10(c) Laws Section 1.01 Legal Restraints Section 6.01(b) Letter Agreement Section 1.01 License Term Section 1.01 Licensed Intellectual Property Section 1.01 Licensed Intellectual Property Rights Section 1.01
Appears in 6 contracts
Samples: Settlement and License Agreement, Settlement and License Agreement, Settlement and License Agreement (Forward Pharma a/S)
